KP.2-based monovalent mRNA vaccines robustly boost antibody responses to SARS-CoV-2
Qian Wang, Ian A. Mellis, Madeline Wu, Anthony Bowen, Carmen Gherasim, Riccardo Valdez, Jayesh Shah, Lawrence J. Purpura, Michael T. Yin, Aubree Gordon, Yicheng Guo, David D. Ho
Topics & Concepts
Messenger RNAVirologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)Antibody2019-20 coronavirus outbreakMedicineImmunologyBiologyComputational biologyGeneticsGeneInternal medicineInfectious disease (medical specialty)DiseaseOutbreakSARS-CoV-2 and COVID-19 ResearchViral Infections and Immunology ResearchAnimal Virus Infections Studies